Optimal adjuvant therapy in clinically N2 non-small cell lung cancer patients undergoing neoadjuvant chemotherapy and surgery: The importance of pathological response and lymph node ratio
Keyword(s):
2011 ◽
Vol 36
(2)
◽
pp. 455-462
◽
Keyword(s):
Keyword(s):
2018 ◽
Vol 55
(3)
◽
pp. 405-412
◽
Keyword(s):
2015 ◽
Vol 33
(15_suppl)
◽
pp. e18529-e18529
Keyword(s):
2016 ◽
Vol 11
(9)
◽
pp. 1565-1573
◽
Keyword(s):
Keyword(s):
Lymph Node Ratio May Predict the Benefit of Postoperative Radiotherapy in Non–Small-Cell Lung Cancer
2013 ◽
Vol 8
(7)
◽
pp. 940-946
◽
Keyword(s):
2016 ◽
Vol 5
(3)
◽
pp. 258-264
◽
Keyword(s):
Keyword(s):